Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer

Ashkenazi A, Pai RC, Fong S et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155–162. doi:10.1172/JCI6926 AshkenaziA PaiRC FongS 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 155 162 10.1172/JCI6926 Open DOISearch in Google Scholar

Azijli K, Weyhenmeyer B, Peters GJ et al (2013) Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: Discord in the death receptor family. Cell Death Differ 20: 858–868. doi:10.1038/cdd.2013.28 AzijliK WeyhenmeyerB PetersGJ 2013 Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: Discord in the death receptor family Cell Death Differ 20 858 868 10.1038/cdd.2013.28 Open DOISearch in Google Scholar

Bai B, Chen H (2021) Metformin: A novel weapon against inflammation. Front Pharmacol 12:622262. doi: 10.3389/fphar.2021.622262 BaiB ChenH 2021 Metformin: A novel weapon against inflammation Front Pharmacol 12 622262 10.3389/fphar.2021.622262 Open DOISearch in Google Scholar

Bavi P, Prabhakaran SE, Abubaker J et al (2010) Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Mol Cancer 9:203. doi:10.1186/1476-4598-9-203 BaviP PrabhakaranSE AbubakerJ 2010 Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations Mol Cancer 9 203 10.1186/1476-4598-9-203 Open DOISearch in Google Scholar

Berlec A, Završnik J, Butinar M et al (2015) In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice. Microb Cell Fact 14:181. doi:10.1186/s12934-015-0376-4 BerlecA ZavršnikJ ButinarM 2015 In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice Microb Cell Fact 14 181 10.1186/s12934-015-0376-4 Open DOISearch in Google Scholar

Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530. doi:10.1038/301527a0 BosmaGC CusterRP BosmaMJ 1983 A severe combined immunodeficiency mutation in the mouse Nature 301 527 530 10.1038/301527a0 Open DOISearch in Google Scholar

Bosma M (1991) The scid mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9:323–350. doi:10.1146/annurev.immunol.9.1.323 BosmaM 1991 The scid mouse mutant: Definition, characterization, and potential uses Annu Rev Immunol 9 323 350 10.1146/annurev.immunol.9.1.323 Open DOISearch in Google Scholar

Carvalho RD, Breyner N, Menezes-Garcia Z et al (2017) Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microb Cell Fact 16:27. doi:10.1186/s12934-017-0624-x CarvalhoRD BreynerN Menezes-GarciaZ 2017 Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis Microb Cell Fact 16 27 10.1186/s12934-017-0624-x Open DOISearch in Google Scholar

Ciaćma K, Wiȩckiewicz J, Kȩdracka-Krok S et al (2018) Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: Optimization of in vitro synthesis conditions. Microb Cell Fact 17:177. doi:10.1186/s12934-018-1028-2 CiaćmaK WiȩckiewiczJ Kȩdracka-KrokS 2018 Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: Optimization of in vitro synthesis conditions Microb Cell Fact 17 177 10.1186/s12934-018-1028-2 Open DOISearch in Google Scholar

Cummins JM, Kohli M, Rago C et al (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64:3006–3008. doi:10.1158/0008-5472.CAN-04-0046 CumminsJM KohliM RagoC 2004 X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells Cancer Res 64 3006 3008 10.1158/0008-5472.CAN-04-0046 Open DOISearch in Google Scholar

DeRoche TC, Xiao SY, Liu X (2014) Histological evaluation in ulcerative colitis. Gastroenterol Rep 2:178–192. doi:10.1093/gastro/gou031 DeRocheTC XiaoSY LiuX 2014 Histological evaluation in ulcerative colitis Gastroenterol Rep 2 178 192 10.1093/gastro/gou031 Open DOISearch in Google Scholar

Dinh CHL, Yu Y, Szabo A et al (2016) Bardoxolone methyl prevents high-fat diet-induced colon inflammation in mice. J Histochem Cytochem 64:237–255. doi:10.1369/0022155416631803 DinhCHL YuY SzaboA 2016 Bardoxolone methyl prevents high-fat diet-induced colon inflammation in mice J Histochem Cytochem 64 237 255 10.1369/0022155416631803 Open DOISearch in Google Scholar

Ehrhardt H, Fulda S, Schmid I et al (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22:3842–3852. doi:10.1038/sj.onc.1206520 EhrhardtH FuldaS SchmidI 2003 TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB Oncogene 22 3842 3852 10.1038/sj.onc.1206520 Open DOISearch in Google Scholar

Evans JP, Sutton PA, Winiarski BK et al (2016) From mice to men: Murine models of colorectal cancer for use in translational research. Crit Rev Oncol Hematol 98:94–105. doi:10.1016/j.critrevonc.2015.10.009 EvansJP SuttonPA WiniarskiBK 2016 From mice to men: Murine models of colorectal cancer for use in translational research Crit Rev Oncol Hematol 98 94 105 10.1016/j.critrevonc.2015.10.009 Open DOISearch in Google Scholar

Galligan L, Longley DB, McEwan M et al (2005) Chemotherapy and TRAIL-mediated colon cancer cell death: The roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 4:2026–2036. doi:10.1158/1535-7163.MCT-05-0262 GalliganL LongleyDB McEwanM 2005 Chemotherapy and TRAIL-mediated colon cancer cell death: The roles of p53, TRAIL receptors, and c-FLIP Mol Cancer Ther 4 2026 2036 10.1158/1535-7163.MCT-05-0262 Open DOISearch in Google Scholar

Ganten TM, Sykora J, Koschny R et al (2009) Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer. J Mol Med 87:995–1007. doi:10.1007/s00109-009-0510-z GantenTM SykoraJ KoschnyR 2009 Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer J Mol Med 87 995 1007 10.1007/s00109-009-0510-z Open DOISearch in Google Scholar

Guilbaud N, Kraus-Berthier L, Meyer-Losic F et al (2001) Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. Clin Cancer Res 7:2573–2580 GuilbaudN Kraus-BerthierL Meyer-LosicF 2001 Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors Clin Cancer Res 7 2573 2580 Search in Google Scholar

Hartwig T, Montinaro A, von Karstedt S et al (2017) The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2. Mol Cell 65:730–742.e5. doi:10.1016/j.molcel.2017.01.021 HartwigT MontinaroA von KarstedtS 2017 The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2 Mol Cell 65 730 742.e5 10.1016/j.molcel.2017.01.021 Open DOISearch in Google Scholar

Herbst RS, Eckhardt SG, Kurzrock R et al (2010) Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. J Clin Oncol 28:2839–2846. doi:10.1200/JCO.2009.25.1991 HerbstRS EckhardtSG KurzrockR 2010 Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer J Clin Oncol 28 2839 2846 10.1200/JCO.2009.25.1991 Open DOISearch in Google Scholar

Hernandez A, Wang Q, Schwartz SA et al (2001) Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 5:56–65. doi:10.1016/S1091-255X(01)80014-7 HernandezA WangQ SchwartzSA 2001 Sensitization of human colon cancer cells to TRAIL-mediated apoptosis J Gastrointest Surg 5 56 65 10.1016/S1091-255X(01)80014-7 Open DOISearch in Google Scholar

Hosono K, Endo H, Takahashi H et al (2010) Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res 3:1077–1083. doi: 10.1158/1940-6207 HosonoK EndoH TakahashiH 2010 Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial Cancer Prev Res 3 1077 1083 10.1158/1940-6207 Open DOISearch in Google Scholar

Jin Z, McDonald ER, Dicker DT et al (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829–35839. doi:10.1074/jbc.M405538200 JinZ McDonaldER DickerDT 2004 Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis J Biol Chem 279 35829 35839 10.1074/jbc.M405538200 Open DOISearch in Google Scholar

Kaczmarek K, Więckiewicz J, Węglarczyk K et al. (2021) The anti-tumor effect of lactococcus lactis bacteria-secreting human soluble trail can be enhanced by metformin both in vitro and in vivo in a mouse model of human colorectal cancer. Cancers 13:3004. doi:10.3390/cancers13123004 KaczmarekK WięckiewiczJ WęglarczykK 2021 The anti-tumor effect of lactococcus lactis bacteria-secreting human soluble trail can be enhanced by metformin both in vitro and in vivo in a mouse model of human colorectal cancer Cancers 13 3004 10.3390/cancers13123004 Open DOISearch in Google Scholar

Kaler P, Augenlicht L, Klampfer L (2009) Macrophage-derived IL-1B stimulates Wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D”3. Oncogene 28:3892–3902. doi:10.1038/onc.2009.247 KalerP AugenlichtL KlampferL 2009 Macrophage-derived IL-1B stimulates Wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D”3 Oncogene 28 3892 3902 10.1038/onc.2009.247 Open DOISearch in Google Scholar

Kaler P, Galea V, Augenlicht L et al (2010) Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1β-dependent stabilization of snail in tumor cells. PLoS One 5:e11700. doi:10.1371/journal.pone.0011700 KalerP GaleaV AugenlichtL 2010 Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1β-dependent stabilization of snail in tumor cells PLoS One 5 e11700 10.1371/journal.pone.0011700 Open DOISearch in Google Scholar

Kamarudin MNA, Sarker MMR, Zhou JR et al (2019) Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. J Exp Clin Cancer Res 38:491. doi: 10.1186/s13046-019-1495-2. KamarudinMNA SarkerMMR ZhouJR 2019 Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects J Exp Clin Cancer Res 38 491 10.1186/s13046-019-1495-2 Open DOISearch in Google Scholar

Kelley SK, Harris LA, Xie D et al (2001) Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 299:31–38 KelleySK HarrisLA XieD 2001 Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety J Pharmacol Exp Ther 299 31 38 Search in Google Scholar

Klijn N, Weerkamp AH, De Vos WM (1995) Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 61:2771–2774. doi:10.1128/aem.61.7.2771-2774.1995 KlijnN WeerkampAH De VosWM 1995 Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract Appl Environ Microbiol 61 2771 2774 10.1128/aem.61.7.2771-2774.1995 Open DOISearch in Google Scholar

Kos B, Šušković J, Goreta J et al (2000) Effect of protectors on the viability of Lactobacillus acidophilus M92 in simulated gastrointestinal conditions. Food Technol Biotechnol 38:121–127 KosB ŠuškovićJ GoretaJ 2000 Effect of protectors on the viability of Lactobacillus acidophilus M92 in simulated gastrointestinal conditions Food Technol Biotechnol 38 121 127 Search in Google Scholar

Lemke J, Von Karstedt S, Zinngrebe J et al (2014) Getting TRAIL back on track for cancer therapy. Cell Death Differ 21: 1350–1364. doi:10.1038/cdd.2014.81 LemkeJ Von KarstedtS ZinngrebeJ 2014 Getting TRAIL back on track for cancer therapy Cell Death Differ 21 1350 1364 10.1038/cdd.2014.81 Open DOISearch in Google Scholar

Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications. J Hematol Oncol 12:76. doi:10.1186/s13045-019-0760-3 LinY XuJ LanH 2019 Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications J Hematol Oncol 12 76 10.1186/s13045-019-0760-3 Open DOISearch in Google Scholar

Ma W, Chen J, Meng Y et al (2018) Metformin alters gut microbiota of healthy mice: Implication for its potential role in gut microbiota homeostasis. Front Microbiol 9:1336. doi:10.3389/fmicb.2018.01336 MaW ChenJ MengY 2018 Metformin alters gut microbiota of healthy mice: Implication for its potential role in gut microbiota homeostasis Front Microbiol 9 1336 10.3389/fmicb.2018.01336 Open DOISearch in Google Scholar

Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686. doi:10.1016/j.it.2004.09.015 MantovaniA SicaA SozzaniS 2004 The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 677 686 10.1016/j.it.2004.09.015 Open DOISearch in Google Scholar

Molloy AM, Ardill J, Tomkin GH (1980) The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects. Diabetologia 19:93–96. doi:10.1007/BF00421851 MolloyAM ArdillJ TomkinGH 1980 The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects Diabetologia 19 93 96 10.1007/BF00421851 Open DOISearch in Google Scholar

Ozawa F, Friess H, Kleeff J et al (2001) Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Lett 163:71–81. doi:10.1016/S0304-3835(00)00660-1 OzawaF FriessH KleeffJ 2001 Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer Cancer Lett 163 71 81 10.1016/S0304-3835(00)00660-1 Open DOISearch in Google Scholar

Park SH, Lee DH, Kim JL et al (2016) Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells. Oncotarget 7:59503–59518. doi:10.18632/oncotarget.11147 ParkSH LeeDH KimJL 2016 Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells Oncotarget 7 59503 59518 10.18632/oncotarget.11147 Open DOISearch in Google Scholar

Pitti RM, Marsters SA, Ruppert S et al (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687–12690. doi:10.1074/jbc.271.22.12687 PittiRM MarstersSA RuppertS 1996 Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 12687 12690 10.1074/jbc.271.22.12687 Open DOISearch in Google Scholar

Saturno G, Valenti M, De Haven Brandon A et al (2013) Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling. Oncotarget 4:1185–1198. doi:10.18632/oncotarget.1162 SaturnoG ValentiM De Haven BrandonA 2013 Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling Oncotarget 4 1185 1198 10.18632/oncotarget.1162 Open DOISearch in Google Scholar

Takayama T, Katsuki S, Takahashi Y et al (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277–1284. doi: 10.1056/NEJM199810293391803 TakayamaT KatsukiS TakahashiY 1998 Aberrant crypt foci of the colon as precursors of adenoma and cancer N Engl J Med 339 1277 1284 10.1056/NEJM199810293391803 Open DOISearch in Google Scholar

Van Dijk M, Halpin-McCormick A, Sessler T et al (2013) Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways. Cell Death Dis 4:e702. doi:10.1038/cddis.2013.214 Van DijkM Halpin-McCormickA SesslerT 2013 Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways Cell Death Dis 4 e702 10.1038/cddis.2013.214 Open DOISearch in Google Scholar

Varfolomeev E, Maecker H, Sharp D et al (2005) Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280:40599–40608. doi:10.1074/jbc.M509560200 VarfolomeevE MaeckerH SharpD 2005 Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand J Biol Chem 280 40599 40608 10.1074/jbc.M509560200 Open DOISearch in Google Scholar

von Karstedt S, Conti A, Nobis M et al (2015) Cancer cell-autonomous TRAIL-R signaling promotes KRAS-Driven cancer progression, invasion, and metastasis. Cancer Cell 27:561–573. doi:10.1016/j.ccell.2015.02.014 von KarstedtS ContiA NobisM 2015 Cancer cell-autonomous TRAIL-R signaling promotes KRAS-Driven cancer progression, invasion, and metastasis Cancer Cell 27 561 573 10.1016/j.ccell.2015.02.014 Open DOISearch in Google Scholar

Wang LX, Zhang SX, Wu HJ et al (2019) M2b macrophage polarization and its roles in diseases. J Leukoc Biol 106:345–358. doi:10.1002/JLB.3RU1018-378RR WangLX ZhangSX WuHJ 2019 M2b macrophage polarization and its roles in diseases J Leukoc Biol 106 345 358 10.1002/JLB.3RU1018-378RR Open DOISearch in Google Scholar

Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682. doi:10.1016/1074-7613(95)90057-8 WileySR SchooleyK SmolakPJ 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 673 682 10.1016/1074-7613(95)90057-8 Open DOISearch in Google Scholar

Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858. doi:10.1038/nm.4345 WuH EsteveE TremaroliV 2017 Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug Nat Med 23 850 858 10.1038/nm.4345 Open DOISearch in Google Scholar

Zhang Y, Davis C, Ryan J et al (2013) Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin Exp Metastasis 30:903–918. doi:10.1007/s10585-013-9591-8 ZhangY DavisC RyanJ 2013 Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver Clin Exp Metastasis 30 903 918 10.1007/s10585-013-9591-8 Open DOISearch in Google Scholar

Zhao X, Li L, Starr TK et al (2017) Tumor location impacts immune response in mouse models of colon cancer. Oncotarget 8:54775–54787. doi:10.18632/oncotarget.18423 ZhaoX LiL StarrTK 2017 Tumor location impacts immune response in mouse models of colon cancer Oncotarget 8 54775 54787 10.18632/oncotarget.18423 Open DOISearch in Google Scholar